Cyclic benzimidazole derivatives useful as anti-diabetic agents
US8410284B2 · kind B2 · utility
0Cited by
6References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 12, 2009 |
| Grant date | Apr 2, 2013 |
| Priority date | — |
| Expiry date | Nov 22, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65583
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds of the structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, Metabolic Syndrome, obesity, hypercholesterolemia, and hypertension.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.